A Screening Computational Tool for Detection of Diabetic Neuropathy and Non-Neuropathy in Type-2 Diabetes Subjects

被引:2
|
作者
Periyasamy, R. [1 ]
Gandhi, T. K. [1 ]
Das, S. R. [2 ]
Ammini, A. C. [3 ]
Anand, S. [1 ]
机构
[1] IIT Delhi, Ctr Biomed Engn, New Delhi 110016, India
[2] VIT, Sch Biol Sci & Engn, Vellore 632014, Tamil Nadu, India
[3] All India Inst Med Sci, Dept Endocrinol & Metab, New Delhi 110016, India
关键词
Type; 2; Diabetes; Neuropathy; Standing Foot Power Ratio (PR); Foot Sole Hardness (H); Artificial Neural Network (ANN); PERIPHERAL NEUROPATHY; FEATURE-SELECTION; FOOT ULCERATION; CLASSIFICATION; PRESSURE; RISK;
D O I
10.1166/jmihi.2012.1093
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Foot problems are common complication in people with diabetes mellitus. An early detection of diabetic neuropathy and non-neuropathy in type 2 diabetes is a crucial test to monitor the nerve damage, sensory loss, pain, numbness and other symptoms in the foot. But available detection techniques are depend on experimental results and highly subjective. Therefore in this study we present artificial neural network (ANN) computational tool for classification of diabetic neuropathy and non-neuropathy from type-2 diabetes subjects by evaluating two parameters (standing foot pressures distribution parameter-Power ratio, foot sole hardness) under the foot sole of different areas. Hardness (H) using shore meter and standing plantar pressure distribution parameter-power ratio (PR) using portable PedoPowerGraph were obtained in the areas of right foot of 170 type-2 diabetes subjects (110 neuropathic patients and 60 non-neuropathic subjects). A sample data (PR and H value) of 40 diabetic subjects (23 were neuropathic and 17 were non-neuropathic) were computed and fed to back propagation feed forward artificial neural network (ANN) for automatic classification of diabetic neuropathy at an early stage, so as to prevent foot ulcer formation and amputation. Our results show that the foot area 2 and 7 are the risk zone for detection of neuropathy with the overall classification accuracy of 94.5%. The average computational time taken by the ANN was 0.75 seconds. The sensitivity and specificity of classifier were found to be 95.6% and 94.1%. Therefore this paper suggests that the proposed classifier is accurate and time efficient compared to other existing systems. However classification accuracy can be further increased with large number of sample data. Hence such computational screening tool can help the clinicians to cross check their diagnosis.
引用
收藏
页码:222 / 229
页数:8
相关论文
共 50 条
  • [41] Microvascular function and wound healing in subjects with type 2 diabetes and neuropathy
    Krishnan, STM
    Baker, NR
    Rayman, G
    DIABETES, 2005, 54 : A216 - A216
  • [42] Antioxidant defense is impaired in type 2 diabetic subjects with painful neuropathy (PN) and cardiovascular autonomic neuropathy (CAN)
    Gillespie, EA
    Marinescu, V
    Larkin, DD
    Pop-Busui, R
    Gillespie, BW
    Stevens, MJ
    DIABETES, 2001, 50 : A185 - A185
  • [43] Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -: Neuropathy and microcirculation in diabetes
    Kasalová, Z
    Prázny, M
    Skrha, J
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (02) : 52 - 57
  • [44] DECREASED COGNITIVE FUNCTION IN TYPE-2 DIABETIC-PATIENTS WITH AUTONOMIC NEUROPATHY
    GROSS, JL
    ZASLAVSKY, LMA
    HUANG, CH
    MACHADO, R
    CHAVES, MLF
    DIABETOLOGIA, 1993, 36 : A185 - A185
  • [45] Sudoscan is an effective screening method for asymptomatic diabetic neuropathy in Chinese type 2 diabetes mellitus patients
    Mao, Fei
    Liu, Siying
    Qiao, Xiaona
    Zheng, Hangping
    Xiong, Qian
    Wen, Jie
    Liu, Lianyong
    Tang, Mingming
    Zhang, Shuo
    Zhang, Zhaoyun
    Ye, Hongying
    Lu, Bin
    Li, Yiming
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (03): : 363 - 368
  • [46] Diabetic peripheral neuropathy screening and the related risk factors to its prevalence in people with type 2 diabetes
    Mohamad Sabaghan
    Shima Ataee
    Maryam Ataee
    Mahsa Tebyanian
    Sima Afrashteh
    Nima Daneshi
    International Journal of Diabetes in Developing Countries, 2023, 43 : 641 - 646
  • [47] The efficacy of pregabalin for treating pain associated with diabetic peripheral neuropathy in subjects with type 1 or type 2 diabetes mellitus
    Parsons, B.
    Li, C.
    Emir, B.
    Vinik, A., I
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (11) : 2015 - 2022
  • [48] Diabetic peripheral neuropathy screening and the related risk factors to its prevalence in people with type 2 diabetes
    Sabaghan, Mohamad
    Ataee, Shima
    Ataee, Maryam
    Tebyanian, Mahsa
    Afrashteh, Sima
    Daneshi, Nima
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (05) : 641 - 646
  • [49] A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes
    Brown, Jennifer J.
    Pribesh, Shana L.
    Baskette, Kimberly G.
    Vinik, Aaron I.
    Colberg, Sheri R.
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [50] Michigan Neuropathy Screening Instrument: A tool for diabetic peripheral neuropathy diagnosis in a rural area in Ecuador
    Bustamante, Daniella
    Velez, Kiara
    Torres, Jorge
    NEUROLOGY, 2023, 100 (17)